Mark T. Reding

Professor and Director
Center for Bleeding and Clotting Disorders, University of Minnesota, Minneapolis, MN, USA
Minneapolis, Minnesota, United States

Presentation(s):

• OC 20.1 - Bleeding, FVIII activity, and safety 3 years after gene transfer with valoctocogene roxaparvovec: Results from GENEr8-1

  Sunday, June 25, 2023
  14:45 – 15:00 ET

• PB0323 - Preliminary Analysis of ATHN 16: Real-World Safety of Eptacog Beta

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB1263 - Third Interim Subgroup Analysis of the Effectiveness and Safety of Damoctocog Alfa Pegol in Patients with Hemophilia A Treated Every 5 or Every 7 Days: Results from the Real-World HEM-POWR Study

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PO19 - Clinical experiences in managing the transition to rIX-FP: switching, surgical management and on-demand

  Wednesday, June 28, 2023
  13:00 – 14:00 ET